Delivery Order SPE2DB20D3101-SPE2DB23FRFL9
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $16,051.21 firm-fixed price delivery order contract to AmerisourceBergen Drug Corp for the provision of SHINGRIX VIAL KITS. This order was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of SHINGRIX vial kits. The $10,451.65 firm-fixed-price contract has a completion date of February 18, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., is a key vendor for federal healthcare programs, particularly within military and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide $3,312.24 worth of SHINGRIX vial kits. The delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,859.40 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SHINGRIX vial kits. This contract does not have a set-aside designation and is scheduled for completion by September 4, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to deliver a wide range of critical medical...
- The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a $48,193.10 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SHINGRIX VIAL KITS, with a period of performance through December 17, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide SHINGRIX VIAL KITS with a ceiling value of $2,208.16. The contract has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is delivering these pharmaceutical products to support military treatment programs and facilities. This delivery order is part of a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,288.10 firm fixed-price delivery order is for SHINGRIX VIAL KITS, a vaccine product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract, number SPE2DX15D3005|SPE2DX24F3QRY, to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $13,656.32 contract is for the provision of SHINGRIX VIAL KITS to support military treatment programs and facilities. This delivery order falls under an indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by DLA to AmerisourceBergen...
- This is a $30,757.80 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SHINGRIX VIAL KITS and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,556.72 Delivery Order contract is for the delivery of SHINGRIX VIAL KITS, a pharmaceutical product, with a performance period ending on May 14, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRFL9Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $20,311.19 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4560298961 SHINGRIX VIAL KITS. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies supporting military and veterans' healthcare programs globally. The contract has no set-aside designation, indicating open competition. AmerisourceBergen, through its extensive distribution capabilities, plays a critical role in delivering essential medications, vaccines, and medical commodities to federal agencies, particularly the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.3k | 3/17/23 |